Differentiation of CD133+ stem cells from amyotrophic lateral sclerosis patients into preneuron cells

Stem Cells Translational Medicine

Volumn 2, Issue 2, 2013, Pages 129-135

  González Garza, Maria Teresa ^a   Martínez, Héctor R ^b   Caro Osorio, Enrique ^b   Cruz Vega, Delia E ^a   Hernández Torre, Martin ^a   Moreno Cuevas, Jorge E ^a  

^a SCHOOL OF ENGINEERING AND SCIENCES   (Mexico)

^b Hospital San Jose Tec de Monterrey   (Mexico)

Author keywords

Amyotrophic lateral sclerosis; Autologous stem cell transplantation; Neural induction; Neurodegenerative diseases; Stem cell differentiation

Indexed keywords

BETA TUBULIN; CD133 ANTIGEN; ENOLASE; GLIAL FIBRILLARY ACIDIC PROTEIN; HOMEODOMAIN PROTEIN; NESTIN; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; TRANSCRIPTION FACTOR HB 9; TRANSCRIPTION FACTOR ISLET 1; TRANSCRIPTION FACTOR NKX6.1; UNCLASSIFIED DRUG;

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CELL ISOLATION; CELL LINEAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FLUORESCENCE MICROSCOPY; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LEUKAPHERESIS; MALE; NERVE CELL DIFFERENTIATION; NEUROINDUCTION MEDIUM; RATING SCALE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL;

EID: 84876510601     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2012-0077     Document Type: Article

References (52)

1. Ringel SP, Murphy JR, Alderson MK et al. The natural history of amyotrophic lateral sclerosis. Neurology 1993;43:1316-1322.
2. Mills KR. The natural history of central motor abnormalities in amyotrophic lateral sclerosis. Brain 2003;126:2558-2566.
3. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998;50:66-72.
4. Zoccolella S, Begh E, Palagano G et al. Analysis of survival and prognostic factors in amyotrophic lateral sclerosis: A population based study. J Neurol Neurosurg Psychiatry 2008;79:33-37.
5. Martínez HR, Molina-Lopez JF, Cantu-Martinez L et al. Survival and clinical features in Hispanic amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler 2011;12:199-205.
6. Bensimon G, Lacomblez L, Meininger V. A controlled trial of riluzole in amyotrophic lateral sclerosis. ALS/Riluzole Study Group. N Engl J Med 1994;330:585-591.
7. Fornai F, Longone P, Cafaro L et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc Natl Acad Sci USA 2008;105:2052-2057.
8. Pasquali L, Longone P, Isidoro C et al. Autophagy, lithium, and amyotrophic lateral sclerosis. Muscle Nerve 2009;40:173-194.
9. Neymotin A, Petri S, Calingasan NY et al. Lenalidomide (Revlimid) administration at symptom onset is neuroprotective in a mouse model of amyotrophic lateral sclerosis. Exp Neurol 2009;220:191-197.
10. Aggarwal SP, Zinman L, Simpson E et al. Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: A randomised, double-blind, placebo-controlled trial. Lancet Neurol 2010;9: 481-488.
11. Kaufmann P, Thompson JL, Levy G et al. QALS Study Group. Phase II trial of CoQ10 for ALS finds insufficient evidence to justify phase III. Ann Neurol 2009;66:235-244.
12. Cova L, Silani V. Amyotrophic lateral sclerosis: Applications of stem cells-an update. Stem Cells Cloning 2010;3:145-156.
13. Liu Y, Zhang SC. Human stem cells as a model of motoneuron development and diseases. Ann NY Acad Sci 2010;1198:192-200.
14. Janson CG, Ramesh TM, During MJ et al. Human intrathecal transplantation of peripheral blood stem cells in amyotrophic lateral sclerosis. J Hematother Stem Cell Res 2001;10: 913-915.
15. Martinez, HR, Gonzalez Garza MT, Moreno Cuevas JE et al. Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients. Cytotherapy 2009;11:26-34.
16. Mazzini L, Fagioli F, Boccaletti R et al. Stem cell therapy in amyotrophic lateral sclerosis: A methodological approach in humans. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:158-161.
17. Silani V, Cova L, Corbo M et al. Stem cell therapy for amyotrophic lateral sclerosis. Lancet 2004;364:200-202.
18. Swash M. Stem cell therapy in human ALS. Amyotroph Lateral Scler Other Motor Neuron Disord 2003;4:133-134.
19. Soler B, Fadic R, von Bernhardi R. Stem cells therapy in amyotrophic lateral sclerosis treatment. A critical view. Rev Neurol 2011;52: 426-434.
20. Svendsen C, Langston JW. Stem cells for Parkinson's disease and ALS: Replacement or protection? Nat Med 2004;10:224-225.
21. Kondziolka D, Steinberg GK, Wechsler L et al. Neurotransplantation for patients with subcortical motor stroke: A phase 2 randomized trial. J Neurosurg 2005;103:38-45.
22. Lima C, Pratas-Vital J, Escada P et al. Olfactory mucosa autografts in human spinal cord injury: A pilot clinical study. J Spinal Cord Med 2006;29:191-203.
23. Moviglia GA, Fernandez Viña R, Brizuela JA et al. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy 2006;8:202-209.
24. Zhou Q, Zhang SZ, Xu RX et al. Neural stem cell transplantation and postoperative management: Report of 70 cases [in Chinese]. Di Yi Jun YI Da Xue XUE Bao 2004;24:1207-1209.
25. De Wynter EA, Buck D, Hart C et al. CD34 AC133 cells isolated from cord blood are highly enriched in long-term culture-initiating cells, NOD/SCID-repopulating cells and dendritic cell progenitors. STEM CELLS 1998;16: 387-396.
26. +() cells. Br J Haematol 2001;115:186-194.
27. + cells. Cell Prolif 2008;41:12-27.
28. + identifies a human bone marrow stem/ progenitor cell sub-population with a repertoire of secreted factors that protect against stroke. Mol Ther 2009;17:1938-1947.
29. Babin-Ebell J, Sievers HH, Charitos EI et al. Transmyocardial laser revascularization combined with intramyocardial endothelial progenitor cell transplantation in patients with intractable ischemic heart disease ineligible for conventional revascularization: Preliminary results in a highly selected small patient cohort. Thorac Cardiovasc Surg 2010;58:11-16.
30. + bone marrow cells to the liver: A novel concept to support hepatic regeneration. STEM CELLS 2005;23:463-470.
31. +-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: Feasibility and safety. Circulation 2005;112:I178-I183.
32. + cell implantation for limb salvage in patients with critical limb ischemia. Bone Marrow Transplant 2010; 45:111-116.
33. + bone marrow stem cells for liver regeneration: Initial experience. Radiology 2007; 243:171-179.
34. +() cells and monocytes provide significant improvement for hindlimb ischemia, although they do not transdifferentiate into endothelial cells. Cell Transplant 2010; 19:103-112.
35. + bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: Safety and efficacy studies. J Thorac Cardiovasc Surg 2007; 133:717-725.
36. + stem cells in Duchenne muscle patients. Cell Transplant 2007;16:563-577.
37. Martínez HR, Molina-Lopez JF, Gonzalez Garza MT et al. Stem cell transplantation in amyotrophic lateral sclerosis patients: Methodological approach, safety and feasibility. Cell Transplant 2012 [Epub ahead of print].
38. Bossolasco P, Cova L, Calzarossa C et al. Metalloproteinase alterations in the bone marrow of ALS patients. J Mol Med 2010;88:553-564.
39. Hermann A, List C, Habisch HJ et al. Age-dependent neuroectodermal differentiation capacity of human mesenchymal stromal cells: Limitations for autologous cell replacement strategies. Cytotherapy 2010;12:17-30.
40. Kaufmann P, Levy G, Thompson JLP et al. The ALSFRS-R predicts survival time in an ALS clinic population. Neurology 2005;64:38-43.
41. Hwang DH, Kim BG, Kim EJ et al. Transplantation of human neural stem cells transduced with Olig2 transcription factor improves locomotor recovery and enhances myelination in the white matter of rat spinal cord following contusive injury. BMC Neurosci 2009;10:117.
42. Lu QR, Yuk D, Alberta JA et al. Sonic hedgehog-regulated oligodendrocyte lineage genes encoding bHLH proteins in the mammalian central nervous system. Neuron 2000;25: 317-329.
43. Zhou Q, Wang S, Anderson DJ. Identification of a novel family of oligodendrocyte lineage-specific basic helix-loop-helix transcription factors. Neuron 2000;25:331-343.
44. Arber S, Han B, Mendelsohn M et al. Requirement for the homeobox gene Hb9 in the consolidation of motor neuron identity. Neuron 1999;23:659-674.
45. Wada T, Honda M, Minami I et al. Highly efficient differentiation and enrichment of spinal motor neurons derived from human and monkey embryonic stem cells. PLoS One 2009; 4:e6722.
46. Ericson J, Thor S, Edlund T et al. Early stages of motor neuron differentiation revealed by expression of homeobox gene Islet-1. Science 1992;256:1555-1560.
47. McMahon A. Neural patterning: The role of Nkx genes in the ventral spinal cord. Genes Dev 2000;14:2261-2264.
48. Kalcheim C, Gendreau M. Brain-derived neurotrophic factor stimulates survival and neuronal differentiation in cultured avian neural crest. Brain Res 1988;469:79-86.
49. Kirschenbaum B, Goldman S. Brain-derived neurotrophic factor promotes the survival of neurons arising from the adult rat forebrain subependymal zone. Proc Natl Acad Sci USA 1995;92:210-214.
50. Ip NY, Li YP, van de Stadt I et al. Ciliary neurotrophic factor enhances neuronal survival in embryonic rat hippocampal cultures. J Neurosci 1991;11:3124-3134.
51. Logan A, Ahmed Z, Baird A et al. Neurotrophic factor synergy is required for neuronal survival and disinhibited axon regeneration after CNS injury. Brain 2006;129:490-502.
52. Ferrero I, Mazzini L, Rustichelli D et al. Bone marrow mesenchymal stem cells from healthy donors and sporadic amyotrophic lateral sclerosis patients. Cell Transplant 2008; 17:255-266.